GRANULES INDIA LTD.-$ - 532482 - Granules India'S Gagillapur Facility Completed The US FDA Inspection.
Granules India's Gagillapur facility completed the US FDA inspection.14-01-2023
14-01-2023
Granules India ties up with Greenko Group for 'green' pharma zones
As a part of the partnership, Granules and Greenko ZeroC will develop and promote state-of-the-art Integrated Green Pharmaceutical Zones (GPZ) with first collaboration in Kakinada, Andhra Pradesh03-01-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules Enters into a Strategic Partnership With Greenko ZeroC To Enable Carbon Free Energy and Green Molecule Solutions03-01-2023
GRANULES INDIA LTD.-$ - 532482 - Closure of Trading Window
Intimation of Trading Window Closure28-12-2022
Buy Granules India; target of Rs 400: Sharekhan
Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 400 in its research report dated December 23, 2022.26-12-2022
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 22 December 2022.
Outcome of the Board meeting dated 22 December 2022.22-12-2022
Granules India to set up packaging unit in the US with $12.5 m investment
Krishna Prasad Chigurupati, Founder and Managing Director, says, This will bolster the robustness of Granules' supply chain'01-12-2022
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Disclosure of resignation of Chief Financial Officer of the Company28-11-2022
GRANULES INDIA LTD.-$ - 532482 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information regarding issuance of Letter of Confirmation in lieu of duplicate share certificate21-11-2022
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting11-11-2022